Jordan Milner, MD - Research

Research at a glance

Focus

Dr. Milner's research focus is graft manipulation. The utilization of graft manipulation permits decreased morbidities and improved quality of life in stem cell transplant recipients.

Active clinical trials

A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Ap

Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a鈥�

Investigator: Jordan Milner
Status: Accepting Candidates
Ages: 0 Years - 25 Years
Sexes: All

(FPBCC) Retrospective CIBMTR Data Analysis

Investigator: Jordan Milner
Status: Accepting Candidates

BMT12108, Non-Myeloablative Conditioning and Bone Marrow Transplantation

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their鈥�

Investigators: Jordan Milner, Biljana Horn
Status: Accepting Candidates
Ages: 1 Year - 70 Years
Sexes: All

My publications

9 publications

2022

Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant

Bone Marrow Transplant

2021

Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation

Bone Marrow Transplant

2018

B-precursor Acute Lymphoblastic Leukemia Complicating 18q Deletion Syndrome

Pediatric Blood Cancer

2009

Impact of physicians鈥� discomfort and patient prognosis on discussion of fertility preservation with young cancer patients

Patient Education and Counseling

BOB体育